Tyra Biosciences, Inc. (TYRA)
NASDAQ · Healthcare
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- $1.95B
- P/E ratio
- —
- EPS
- —
- Volume
- 342,579
- 52-week high
- —
- 52-week low
- —
- Open
- $32.05
- Day high
- $33.05
- Day low
- $31.03
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2025 | — | -$119.95M | -$2.01 |
| 2024 | — | -$86.48M | -$1.51 |
| 2023 | — | -$69.13M | -$1.62 |
| 2022 | — | -$55.33M | -$1.32 |
| 2021 | — | -$26.29M | -$1.91 |
About Tyra Biosciences, Inc.
Tyra Biosciences, Inc. is a preclinical biopharmaceutical company focused on innovating treatments to tackle tumor resistance and enhance patient outcomes in oncology. Its flagship product candidate, TYRA-300, is a highly selective inhibitor of fibroblast growth factor receptor (FGFR)3, specifically engineered for the treatment of muscle-invasive bladder cancer. Beyond this, the company is advancing a pipeline of programs addressing other critical conditions, including FGFR2-related intrahepatic cholangiocarcinoma, FGFR3-associated achondroplasia, REarranged during transfection (RET) kinase aberrations, and various FGFR4-driven cancers. Tyra also leverages its proprietary SNAP platform, designed to accelerate structural drug design through an iterative molecular 'snapshot' approach. Founded in 2018, Tyra Biosciences maintains its headquarters in Carlsbad, California.
- CEO
- Todd Harris
- Employees
- 87
- Country
- US
- IPO date
- Sep 15, 2021
Similar stocks
Other Healthcare companies
Frequently asked questions
- What is Tyra Biosciences, Inc.'s stock price today?
- TYRA is trading at $31.06 as of Jul 20, 2026.
- What is Tyra Biosciences, Inc.'s market cap?
- Tyra Biosciences, Inc. (TYRA) has a market capitalization of $1.95B.
- Does Tyra Biosciences, Inc. pay a dividend?
- Tyra Biosciences, Inc. did not pay a dividend in its most recent reported fiscal year.
- What sector is Tyra Biosciences, Inc. in?
- Tyra Biosciences, Inc. operates in the Healthcare sector.